Back to home page

AN OUTSTANDING INNOVATION POLICY

The Mérieux Research Grants

These research grants are designed to promote and identify innovative projects. They provide investigators (junior, senior, in the medical or scientific community) in public and private laboratories with the funding needed to conduct projects on infectious diseases, cancer and cardiovascular diseases, nutrition, food and water safety.

All applications go through a rigorous review process. Those that are selected are awarded a two-year grant (up to € 200,000), with Institut Mérieux having the option of establishing strategic partnerships in the event of success.

There are two types of grants:

  • Advanced Research Grants for the most innovative projects having significant strategic advantages,
  • Starting Research Grants for projects that, although interesting, must clearly demonstrate their feasibility

To know more about the Mérieux Research Grants, please click here.

To submit your project, click here

Merieux Alliance

Selected projects


Mérieux Research Grants 2016

Dan ANDERSSONUppsala University – Uppsala - Sweden

  • Bacterial biofilms: Impact of sub-MIC concentrations of antibiotics on biofilm formation and selection for resistance

Lionel APETOHInserm UMR 866 – Dijon – France

  • Role of autophagy in Th9 cell differenciation

Monsef BENKIRANECNRS Montpellier – France

  • Understanding the contribution of host cell fators SAMHD1 and SLX4 complex to viral persistence and innate immune response

Ken CADWELLNew York University School of Medicine - New York - États-Unis

  • Identifying novel members of the microbiota that inhibit inflammatory bowel disease

Agostino CARVALHOUniversity of Minho – Braga – Portugal

  • Stratafun – translating the host microbiota interaction into risk assessment of fungal diseases

Laurent GILLETUniversity of Liege – Belgium

  • Study of the mechanisms by which a gammaherpesvirus protects its host from airway allergy

Dan LITTMANNew York University School of Medicine – USA

  • Effect of microbiota-specific T cell modulation on tumor growth and response to immunotherapy

Feng SHAONational Institute of Biological Sciences (NIBS) - Beijing - China

  • GSDMD-mediated pyroptosis in anti-bacterial defense, autoinflammatory diseases and sepsis

Ivan TANCEVSKIInnsbruck Medical University – Innsbruck – Austria

  • genetically engineered E Coli nissle as probiotic to treat cardiovascular disease

Jessica ZUCMAN ROSSIInserm U1162 – Paris – France

  • Role of AAV infection in human liver : relationship with inflammation and tumorigenesis

Mérieux Research Grants 2015

Ruedi AEBERSOLDETH Zurich, Zurich, Switzerland

  • Towards a global, dynamic map of protein complexes in mycobacteria via SWATH mass spectrometry

Moran BERCOVICITechnion, Israel Institute of Technology, Israel

  • Microfluidic platform for amplification-free detection of pathogens usins isotachophoreses and peptide nucleic acids

Gwladys BERTIN – Philippe DELORONInstitut de recherché pour le développement – Paris

  • Identification of virulence factors in cerebral malaria – CIVIC

Gary BRITTENHAMColumbia University – New York – USA

  • Non-invasive detection of iron deficiency for targeted iron supplementation in regions with malaria and other infections

Georgios CHAMILOSUniversity of Crete – Heraklion – Crete

  • Dissecting the role of LC3 associated phagocytosis (LAP) in sepsis-induced immunoparesis

Charles CHIUUniversity of California – San Francisco - USA

  • Real-time detection of bloodborne pathogens by unbiased nanopore sequencing

Guido KROEMERInserm U848 – Paris

  • Caloric restriction, autophagy, obesity and metabolism: a strategy for identifying caloric restriction mimetics

Pierre LAURENT-PUIGInserm 1147 – Paris

  • Digital PCR and circulating plasmatic DNA : a multi-cancers analysis

Amit MELLERTechnion – Haifa – Israel

  • An ultra sensitive nanopore biosensors for detection of KRAS mutations in colorectal cancer

Nira POLLOCKBCH – Boston Children’s Hospital – Boston – USA

  • Quantification of C. difficile toxins A and B by digital ELISA: correlations with disease severity and response to therapy

Asya ROLLSRappaport medical school Technion – Haifa – Israel

  • Role of local neuronal innervation on anti-tumor immunity in breast cancer

Ester SEGALTechnion - Haifa, Israel

  • Bacterial Antibiotics Susceptibility: Growth Dependent Analysis Using Porous Silicon Arrays

Mérieux Research Grants 2014

Sergio ABRIGNANIInstitute Nationale de Genetica Moleculaire – Milan - Italy

  • Serum microRNA released by CD4 T cell subsets

Anca DORHOIMax Planck Institute for Infection Biology - Berlin - Germany

  • Deciphering the cross-talk between myeloid cells and pneumocytes during lung microbial infections

Brett FINLAYUniversity of british Columbia – Vancouver - Canada

  • Use of microbiota and their metabolites to develop novel methods to control enteric infectious diseases

Michael GILMOREHarvard medical School – Boston - USA

  • Exploring the staphyllococcus aureus innate "Resistome" using next generation sequencing technology, Tn-seq

Jens HASSERODTEcole Normale Supérieure de Lyon - France

  • Pushing FACS-based detection sensitivity to new heights in the ultrahigh-throughput screening of enzyme variants

Kim LEWISNortheastern University – Boston - USA

  • Die Hard : how M Tuberculosis survives antibiotic treatment

Stephen LORYHarvard Medical School – Boston – USA

  • A comprehensive analysis of Acinetobacter baumannii virulence and host-recognition factors

Scott MANALISMIT– Cambridge - USA

  • Resonant microchannels with droplets for rapid antibiotic susceptibility testing

Sarkis K. MAZMANIANCalifornia Institute of Technology – Pasadena - USA

  • Novel Microbiome Therapies for Parkinson’s Disease

Sven PETTERSSONKarolinska Institute – Stockholm - Sweden

  • The MICROBIOM – a key player involved in the developmental programming of the brain

Kyu RHEEWeill Cornell Medical College - New York - USA

  • Metabolomic biomarkers of Mtb drug susceptibility

Henriqueta SILVAFaculté de medicine – Coimbra - Portugal

  • The pharmacogenomics in the personalization of isoniazid treatment of patients with tuberculosis

Michael SNYDERStanford University – Stanford - USA

  • Integrative omics profiling for monitoring health an disease

Simon TAYLOR ROBINSONImperial College – London - UK

  • A novel low cost, urinary diagnostic

Marc VIDALDana Farber – Boston - USA

  • Identification of Cancer Associated Rewiring Edgotypes

Marie Lucia FERRAZ (Network)University of Sao Paolo – Brazil

  • Clonal evaluation of KPC isolates from hospital complex in clinical hospitals

Fang LI (Fellowship)University of Heifei - China

  • Luminescence functionalized nanomaterials for label-free bioassays Fellowship (3K€) - 2014